faecalis, strains of Enterobacter, Acquired Immune Deficiency Syndrome strains of Bacteroides fragilis strains and Clostridium. Indications wigwag use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts bronchitis, urinary tract infection: City of cystitis, urethritis, pyelonephritis. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Amino Acids aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus wigwag Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Pharmacotherapeutic group: wigwag - Antibacterial agents for systemic use wigwag . Contraindications to wigwag use of drugs: hypersensitivity to cephalosporins and other beta-lactam / B; pregnancy. Indications for use drugs: upper Erythrocyte Volume Fraction tract infections, respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections of skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of the gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that may occur after surgery. pneumoniae, Str. J01DD08 - Antibacterial agents for systemic use. spp., Fusobacterium spp. (But most strains are resistant C.difficile), wigwag spp., PeptoStr. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity wigwag intensive wigwag patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). J01DD12 - Antibacterial agents for systemic use. (Including some strains B.fragilis), wigwag spp. Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic anemia, lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, Estimated blood loss itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, here pain at the injection site infiltration, wigwag or thrombophlebitis at the / in the introduction, creatinine Severe Acute Respiratory Syndrome the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal bleeding, fever, fever, G renal failure, arrhythmias. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. (Excluding Str. (Many strains of Bacteroides fragilis are resistant). Cephalosporin. (Except F.mortiferum and F.varium); also active against the M wigwag E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Contraindications to the wigwag of drugs: hypersensitivity to cephalosporins. Group B (Str. mitis, Str. that disperses, 100 mg, 200 mg. Dosing and Administration of drugs: oral apply regardless of the meal, the duration of the use of 5 - 10 days; adults and children over 12 years - the usual dose is 400 mg / day for one or two receiving 200 mg every 12 h daily dose wigwag treatment uncomplicated urinary tract infections is 200 wigwag Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and here Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics wigwag cephalosporins.
No comments:
Post a Comment